331 related articles for article (PubMed ID: 16323216)
1. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
Hain B; Jordan K; Deschauer M; Zierz S
Muscle Nerve; 2006 Apr; 33(4):575-80. PubMed ID: 16323216
[TBL] [Abstract][Full Text] [Related]
2. Anti-MuSK myasthenia gravis with prolonged remission.
Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis with antibodies to MuSK: an update.
Evoli A; Alboini PE; Damato V; Iorio R; Provenzano C; Bartoccioni E; Marino M
Ann N Y Acad Sci; 2018 Jan; 1412(1):82-89. PubMed ID: 29266255
[TBL] [Abstract][Full Text] [Related]
4. [Therapy for anti-MuSK antibody positive myasthenia gravis].
Pál Z; Boczán J; Bereznai B; Lovas G; Molnár MJ
Orv Hetil; 2011 Sep; 152(39):1586-9. PubMed ID: 21920845
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
Stein B; Bird SJ
J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
[No Abstract] [Full Text] [Related]
6. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
Yamada C; Teener JW; Davenport RD; Cooling L
J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in refractory MuSK antibody myasthenia gravis.
Thakre M; Inshasi J; Marashi M
J Neurol; 2007 Jul; 254(7):968-9. PubMed ID: 17468964
[No Abstract] [Full Text] [Related]
8. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.
Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A
Front Immunol; 2020; 11():613. PubMed ID: 32431692
[TBL] [Abstract][Full Text] [Related]
9. Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
Illa I; Diaz-Manera J; Rojas-Garcia R; Pradas J; Rey A; Blesa R; Juarez C; Gallardo E
J Neuroimmunol; 2008 Sep; 201-202():90-4. PubMed ID: 18653247
[TBL] [Abstract][Full Text] [Related]
10. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis: emerging new therapy options.
Sieb JP
Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
[TBL] [Abstract][Full Text] [Related]
12. Longstanding and Refractory Anti-Muscle Specific Tyrosine Kinase Antibody-Associated Myasthenia Gravis (Anti-MuSK-MG) in a Child Successfully Treated with Rituximab.
Weger S; Appendino JP; Clark IH
J Binocul Vis Ocul Motil; 2019; 69(1):26-29. PubMed ID: 30811277
[TBL] [Abstract][Full Text] [Related]
13. Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.
Govindarajan R; Iyadurai SJ; Connolly A; Zaidman C
Neuromuscul Disord; 2015 Aug; 25(8):651-2. PubMed ID: 25998611
[TBL] [Abstract][Full Text] [Related]
14. Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
Kuntzer T; Carota A; Novy J; Cavassini M; Du Pasquier RA
Neurology; 2011 Feb; 76(8):757-8. PubMed ID: 21339503
[No Abstract] [Full Text] [Related]
15. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
[TBL] [Abstract][Full Text] [Related]
16. Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.
Keung B; Robeson KR; DiCapua DB; Rosen JB; O'Connor KC; Goldstein JM; Nowak RJ
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1407-9. PubMed ID: 23761915
[No Abstract] [Full Text] [Related]
17. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
18. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
Hain B; Hanisch F; Deschauer M
Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
[TBL] [Abstract][Full Text] [Related]
19. Refractory bulbar and respiratory dysfunction in a young Chinese woman with seronegative, muscle-specific tyrosine kinase antibody-positive myasthenia gravis: response to cyclophosphamide and rituximab treatment.
Lau AY; Chan AY; Mok VC
Hong Kong Med J; 2011 Feb; 17(1):77-9. PubMed ID: 21282832
[TBL] [Abstract][Full Text] [Related]
20. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
